Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivo.

Arreba-Tutusaus, P; Mack, T S; Bullinger, L; Schnöder, T M; Polanetzki, A; Weinert, S; Ballaschk, A; Wang, Z; Deshpande, A J; Armstrong, S A; Döhner, K; Fischer, T; Heidel, F H

Arreba-Tutusaus, P; Mack, T S; Bullinger, L; Schnöder, T M; Polanetzki, A; Weinert, S; Ballaschk, A; Wang, Z; Deshpande, A J; Armstrong, S A; Döhner, K; Fischer, T; Heidel, F H.

Affiliation

Arreba-Tutusaus P; Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Saxony-Anhalt, Germany.
Mack TS; Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Saxony-Anhalt, Germany.
Bullinger L; Department of Internal Medicine III, University of Ulm, Ulm, Baden-Württemberg, Germany.
Schnöder TM; Department of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Polanetzki A; Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Saxony-Anhalt, Germany.
Weinert S; Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Saxony-Anhalt, Germany.
Ballaschk A; Department of Cardiology and Angiology, Center of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Saxony-Anhalt, Germany.
Wang Z; Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Saxony-Anhalt, Germany.
Deshpande AJ; Department of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Armstrong SA; Department of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Döhner K; Tumor Initiation and Maintenance, Sanford Burnham Medical Research Institute, La Jolla, CA, USA.
Fischer T; Department of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Heidel FH; Human Oncology and Pathogenesis Program and Department of Pediatrics, Memorial Sloan-Kettering Cancer Institute, New York, NY, USA.

Leukemia ; 30(5): 1220-1225, 2016 05.

Article de En | MEDLINE | ID: mdl-26487272

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protein-tyrosine kinases / Leucémie aigüe myéloïde / Inhibiteurs de protéines kinases / Tyrosine kinase-3 de type fms Type d'étude: Diagnostic_studies Limites: Animals / Humans Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2016 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google